📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Diagnoplex

1.1 - Company Overview

Diagnoplex Logo

Diagnoplex

Headquarter: Switzerland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of non-invasive colorectal cancer screening tests and diagnostics, including the COLOX colorectal cancer screening test; the company has conducted a 140-patient prospective pilot study demonstrating technical and clinical feasibility.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Diagnoplex

Singleron Logo

Singleron

HQ: China Website
  • Description: Provider of clinical diagnosis, health management, and drug development products and services, dedicated to applying single cell analysis techniques. Holds a worldwide exclusive IP license from Yale University for a uniquely designed microfluidic single cell processing device.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Singleron company profile →
Inari Logo

Inari

HQ: United States Website
  • Description: Provider of seed design and biotechnology focused on developing seeds for a nature-positive food system, leveraging predictive design and multiplex gene editing to transform agriculture and its impact on society and the environment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Inari company profile →
Organ-i Logo

Organ-i

HQ: United States Website
  • Description: Provider of novel biotech diagnostic tests for renal diseases, improving clinicians’ ability to monitor the health of transplanted kidneys and providing valuable treatment information for patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Organ-i company profile →
Eligo Bioscience Logo

Eligo Bioscience

HQ: France Website
  • Description: Provider of CRISPR/Cas and engineered phage capsid-based antimicrobials and microbiome editing technologies to control bacterial ecosystems in humans and animals. Solutions include the GEM platform for in vivo gene editing, SSAM sequence-specific antimicrobials, FAME for therapeutic gene addition, and capabilities for gene removal, modification, and addition to eradicate resistant pathogens and modulate disease mechanisms.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eligo Bioscience company profile →
RareCyte Logo

RareCyte

HQ: United States Website
  • Description: Provider of rare cell characterization and isolation solutions for life science research and diagnostic development, including the Orion Platform for whole slide multimodal imaging in spatial biology and biomarker quantitation; CyteFinder II for high-speed imaging with multiplexed liquid biopsy and tissue spatial analysis and single-cell or tissue micro-region retrieval; AccuCyte for isolating circulating tumor cells; Precision Biology Services; and customizable Orion biomarker panels for FFPE or frozen tissue.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RareCyte company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Diagnoplex

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Diagnoplex

2.2 - Growth funds investing in similar companies to Diagnoplex

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Diagnoplex

4.2 - Public trading comparable groups for Diagnoplex

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Diagnoplex

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Diagnoplex

What does Diagnoplex do?

Diagnoplex is a provider of non-invasive colorectal cancer screening tests and diagnostics, including the COLOX colorectal cancer screening test; the company has conducted a 140-patient prospective pilot study demonstrating technical and clinical feasibility.

Who are Diagnoplex's competitors?

Diagnoplex's competitors and similar companies include Singleron, Inari, Organ-i, Eligo Bioscience, and RareCyte.

Where is Diagnoplex headquartered?

Diagnoplex is headquartered in Switzerland.

How many employees does Diagnoplex have?

Diagnoplex has 1,000 employees 🔒.

When was Diagnoplex founded?

Diagnoplex was founded in 2010 🔒.

What sector and industry vertical is Diagnoplex in?

Diagnoplex is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Diagnoplex

Who are the top strategic acquirers in Diagnoplex's sector and industry

Top strategic M&A buyers and acquirers in Diagnoplex's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Diagnoplex?

Top strategic M&A buyers groups and sectors for Diagnoplex include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Diagnoplex's sector and industry vertical

Which are the top PE firms investing in Diagnoplex's sector and industry vertical?

Top PE firms investing in Diagnoplex's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Diagnoplex's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Diagnoplex's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Diagnoplex's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Diagnoplex include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Diagnoplex's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Diagnoplex?

The key public trading comparables and valuation benchmarks for Diagnoplex include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Diagnoplex for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Diagnoplex with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Diagnoplex's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Diagnoplex with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Diagnoplex's' sector and industry vertical?

Access recent funding rounds and capital raises in Diagnoplex's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Diagnoplex